About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 403 record(s)
Req # A-2020-000981
All records pertaining to the front-of-package labelling initiative and regulations proposed by the government in 2018, including any briefing notes or other prepared documents from the Director Genreal (DG) level and above.Organization: Health Canada
August 2022
Req # A-2021-000558
As part of a study on the production of organic and sustainable cosmetics in Canada, a listing of all Canadian cosmetics manufacturers who are registered in accordance with Health Canada's "Notification of Cosmetics," as per section 30 of the Cosmetic Regulations.Organization: Health Canada
August 2022
Req # A-2021-001018
All records of correspondence with the Government of Saskatchewan officials regarding COVID-19 assistance since September 1, 2021.Organization: Health Canada
August 2022
Req # A-2021-001236
The Health Canada Generic Submissions Under Review List, an Abbreviated New Drug Submission (ANDS) for degarelix acetate was submitted on or after October 1, 2018. Please provide the generic product’s full composition, including all data regarding the list of ingredients of the new drug, stated quantitatively, and the specifications for each of those ingredients, as described in paragraph C.08.002(2)(c) of the Food and Drug Regulations and as required by section 2.3.P.1 of the Quality Overall Summary – Chemical Entities (New Drug Submissions/Abbreviated New Drug Submissions) (QOS-CE (NDS/ANDS)).Organization: Health Canada
August 2022
Req # A-2021-001245
The Health Canada Generic Submissions Under Review List, an Abbreviated New Drug Submission (ANDS) for degarelix acetate was submitted on or after October 1, 2018. All records containing information regarding the evidence of clinical effectiveness of the new drug for the purpose and under the conditions of use recommended, as described in paragraph C.08.002(2)(h) of the Food and Drug Regulations.Organization: Health Canada
August 2022
Req # A-2021-001342
Full copies of all adverse reaction reports with the suspected active ingredient glucagon received by Health Canada between January 1, 2021 and November 10, 2021.Organization: Health Canada
August 2022
Req # A-2021-002007
Copies of the Quality Overall Summary (QOS) for the following products: Palbociclib tablets: Drug Identification Number (DIN) 02493535, DIN 02493543, DIN 02493551.Organization: Health Canada
August 2022
Req # A-2021-002056
The standard applied by Health Canada for determining whether a vaccine is "safe".Organization: Health Canada
August 2022
Req # A-2022-000070
Identify all Health Canada mandated studies of airborne and waterborne hazards at Canadian Security Intelligence Service (CSIS) offices across Canada, the dates these studies were mandated and the results of these findings. The period under review consist of 2000 to 2022.Organization: Health Canada
August 2022
Req # A-2022-000159
The current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product (Control No. 245431), which was accepted into review by Health Canada on February 26, 2021.Organization: Health Canada
August 2022